The treatment of breast cancer cell lines, MCF-7 and MDA-MB-231, with andrographolide, demonstrates an inhibition of Bcl-2 and an increase in the expression and protein levels of Bax, further demonstrating the apoptotic effect of andrographolide on these breast cancer cell lines (142). The gene discussed is BAX; the disease is breast cancer.